IBDEI0AL ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4939,1,2,0)
 ;;=2^136.1
 ;;^UTILITY(U,$J,358.3,4939,1,5,0)
 ;;=5^Behcet's Syndrome
 ;;^UTILITY(U,$J,358.3,4939,2)
 ;;=^13205
 ;;^UTILITY(U,$J,358.3,4940,0)
 ;;=705.89^^39^398^2
 ;;^UTILITY(U,$J,358.3,4940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4940,1,2,0)
 ;;=2^705.89
 ;;^UTILITY(U,$J,358.3,4940,1,5,0)
 ;;=5^Bromhidrosis
 ;;^UTILITY(U,$J,358.3,4940,2)
 ;;=^271930
 ;;^UTILITY(U,$J,358.3,4941,0)
 ;;=700.^^39^399^7
 ;;^UTILITY(U,$J,358.3,4941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4941,1,2,0)
 ;;=2^700.
 ;;^UTILITY(U,$J,358.3,4941,1,5,0)
 ;;=5^Corns And Callosities
 ;;^UTILITY(U,$J,358.3,4941,2)
 ;;=^18351
 ;;^UTILITY(U,$J,358.3,4942,0)
 ;;=709.09^^39^399^2
 ;;^UTILITY(U,$J,358.3,4942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4942,1,2,0)
 ;;=2^709.09
 ;;^UTILITY(U,$J,358.3,4942,1,5,0)
 ;;=5^Cafe au lait spot
 ;;^UTILITY(U,$J,358.3,4942,2)
 ;;=^303313
 ;;^UTILITY(U,$J,358.3,4943,0)
 ;;=709.3^^39^399^3
 ;;^UTILITY(U,$J,358.3,4943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4943,1,2,0)
 ;;=2^709.3
 ;;^UTILITY(U,$J,358.3,4943,1,5,0)
 ;;=5^Calcinosis,Skin
 ;;^UTILITY(U,$J,358.3,4943,2)
 ;;=^31460
 ;;^UTILITY(U,$J,358.3,4944,0)
 ;;=380.00^^39^399^4
 ;;^UTILITY(U,$J,358.3,4944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4944,1,2,0)
 ;;=2^380.00
 ;;^UTILITY(U,$J,358.3,4944,1,5,0)
 ;;=5^Chondrodermatitis Nodularis Helicis
 ;;^UTILITY(U,$J,358.3,4944,2)
 ;;=^269337
 ;;^UTILITY(U,$J,358.3,4945,0)
 ;;=706.2^^39^399^8
 ;;^UTILITY(U,$J,358.3,4945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4945,1,2,0)
 ;;=2^706.2
 ;;^UTILITY(U,$J,358.3,4945,1,5,0)
 ;;=5^Cyst,Epidermal
 ;;^UTILITY(U,$J,358.3,4945,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,4946,0)
 ;;=078.11^^39^399^6
 ;;^UTILITY(U,$J,358.3,4946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4946,1,2,0)
 ;;=2^078.11
 ;;^UTILITY(U,$J,358.3,4946,1,5,0)
 ;;=5^Condyloma NOS
 ;;^UTILITY(U,$J,358.3,4946,2)
 ;;=^295788
 ;;^UTILITY(U,$J,358.3,4947,0)
 ;;=710.1^^39^399^1
 ;;^UTILITY(U,$J,358.3,4947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4947,1,2,0)
 ;;=2^710.1
 ;;^UTILITY(U,$J,358.3,4947,1,5,0)
 ;;=5^CRST Syndrome
 ;;^UTILITY(U,$J,358.3,4947,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,4948,0)
 ;;=078.11^^39^399^5
 ;;^UTILITY(U,$J,358.3,4948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4948,1,2,0)
 ;;=2^078.11
 ;;^UTILITY(U,$J,358.3,4948,1,5,0)
 ;;=5^Condyloma Accuminatum
 ;;^UTILITY(U,$J,358.3,4948,2)
 ;;=^295788
 ;;^UTILITY(U,$J,358.3,4949,0)
 ;;=216.8^^39^400^1
 ;;^UTILITY(U,$J,358.3,4949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4949,1,2,0)
 ;;=2^216.8
 ;;^UTILITY(U,$J,358.3,4949,1,5,0)
 ;;=5^Dermatofibroma
 ;;^UTILITY(U,$J,358.3,4949,2)
 ;;=^267637
 ;;^UTILITY(U,$J,358.3,4950,0)
 ;;=710.3^^39^400^3
 ;;^UTILITY(U,$J,358.3,4950,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4950,1,2,0)
 ;;=2^710.3
 ;;^UTILITY(U,$J,358.3,4950,1,5,0)
 ;;=5^Dermatomyositis
 ;;^UTILITY(U,$J,358.3,4950,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,4951,0)
 ;;=709.00^^39^400^5
 ;;^UTILITY(U,$J,358.3,4951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4951,1,2,0)
 ;;=2^709.00
 ;;^UTILITY(U,$J,358.3,4951,1,5,0)
 ;;=5^Dyschromia
 ;;^UTILITY(U,$J,358.3,4951,2)
 ;;=^37473
 ;;^UTILITY(U,$J,358.3,4952,0)
 ;;=709.9^^39^400^4
 ;;^UTILITY(U,$J,358.3,4952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4952,1,2,0)
 ;;=2^709.9
 ;;^UTILITY(U,$J,358.3,4952,1,5,0)
 ;;=5^Dermatosis NOS
 ;;^UTILITY(U,$J,358.3,4952,2)
 ;;=^111083
 ;;^UTILITY(U,$J,358.3,4953,0)
 ;;=708.3^^39^400^2
 ;;^UTILITY(U,$J,358.3,4953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4953,1,2,0)
 ;;=2^708.3
